Syphilis is a chronic infection caused by the spirochete bacterium Treponema pallidum subsp. pallidum. Numerous studies have demonstrated that T. pallidum attaches to host cells (2, 3, 11-14, 16, 21, 37, 45, 48, 50) . Experimentally induced infections (7, 36) and in vitro studies (48) have shown that T. pallidum adheres to epithelial surfaces, traverses the tissue barrier, and enters the circulation by invading the tight junctions between endothelial cells. Treponemal invasion results in widespread bacterial dissemination, which sets the stage for establishment of chronic infection.
Specific attachment to the extracellular matrix (ECM) component fibronectin has been documented for many pathogenic bacteria, including the related spirochetes Borrelia burgdorferi (19, 35) , Leptospira interrogans (26) , and Treponema denticola (8) (9) (10) 49) . Fibronectin is also likely to be involved in T. pallidum cytoadherence. The organism specifically attaches to fibronectin-coated surfaces (21, 34) , and fibronectin synthesis by fibroblasts is upregulated in areas of ulceration, including syphilis chancres formed at the primary site of infection. In addition, pretreatment of host cells with antiserum to fibronectin, but not control irrelevant antiserum, inhibits attachment of T. pallidum (21, 34, 45) . Finally, three T. pallidum fibronectinbinding proteins, designated P1, P2, and P3, were previously identified by fibronectin affinity chromatography and radioimmunoprecipitation techniques (1, 33, 34, 46) . The molecular masses of these proteins were determined to be 89.5, 37, and 32 kDa for P1, P2, and P3, respectively (46); however, their molecular identities remain unknown.
T. pallidum fibronectin-binding proteins. To identify T. pallidum fibronectin-binding proteins, 10 potential adhesins were tested for their capacity to mediate attachment of fibronectin. These putative adhesins were identified via bioinformatic analysis of the T. pallidum genome (18) and expressed as recombinant proteins, as described in detail elsewhere (5) . Enzymelinked immunosorbent assay (ELISA) plates (Nalge Nunc International, Rochester, N.Y.) were coated for 16 h at room temperature with 100 l of the recombinant T. pallidum proteins, a positive control S. aureus fibronectin-binding protein (FnbpA) (41) , and a negative control recombinant protein (SA85-1.1) (23) , all at a concentration of 5 g/ml in phosphatebuffered saline (PBS). Wells were subsequently washed three times with PBS. For the adherence assays, 100 l of either soluble or matrix fibronectin (Sigma, St. Louis, Mo.) was added to the wells at a concentration of 5 g/ml. To test for the dose-dependent attachment of fibronectin, 100 l of various matrix or soluble fibronectin concentrations ranging from 0 to 5 g/ml in PBS was added to the wells. After incubation for 1 h at room temperature, wells were washed six times with PBS with 0.05% Tween-20 (PBST) and bound fibronectin was detected with rabbit anti-human fibronectin (1:500 dilution; Sigma) and goat anti-rabbit immunoglobulin G-horseradish peroxidase conjugate (1:2,000; Sigma) followed by the TMB Microwell peroxidase substrate (Kirkegaard and Perry Laboratories, Gaithersburg, Md.). Optical densities were read at 600 nm with an ELISA plate reader (Bio-Tek Instruments, Winooski, Vt.).
Of the panel of expressed T. pallidum recombinant proteins, fibronectin exhibited a significant level of attachment to Tp0155 and Tp0483 (P Ͻ 0.05) (Fig. 1) . Each of these proteins, as well as the positive control protein, bound increasing concentrations of fibronectin in a dose-dependent manner, compared to a minimal level of fibronectin attachment observed to the negative control recombinant protein ( Fig. 2A) . The capacity of Tp0155 and Tp0483 to interact with two different forms of fibronectin was also investigated: soluble dimeric fibronectin, which resembles the form found in plasma, and superfibronectin, a multimeric form of fibronectin that most closely resembles the form found in the extracellular matrix (27, 28) . Tp0155 preferentially bound the matrix form of fibronectin, whereas Tp0483 bound both the soluble and matrix forms of fibronectin (Fig. 2B) .
Inhibition experiments. The involvement of Tp0155 and Tp0483 in mediating attachment of T. pallidum to fibronectin was directly assayed via in vitro inhibition experiments. Slides were coated with 4 g of matrix fibronectin in PBS on Lab-Tek II chamber slides (Nalge Nunc International) by incubation for 16 h at room temperature. After washing with PBS, slides were blocked for 2 h with 3% bovine serum albumin. Inhibition experiments were performed by preincubating fibronectincoated slides with 200-g/ml samples of either Tp0155 or Tp0483, both Tp0155 and Tp0483, or the negative control recombinant proteins Tp0751 and Tp0952. After washing with PBS, slides were incubated for 2 h at 34°C with 3 ϫ 10 7
Percoll-purified T. pallidum (20) . After gentle washing with saline (10 times for 5 min each), the attached spirochetes were visualized by dark-field microscopy and quantitative attachment was determined by calculating the number of attached treponemes per field. As shown in Fig. 3 , preincubation of fibronectin-coated slides with Tp0155 or Tp0483, either alone or in combination, significantly decreased the number of adherent treponemes (P Ͻ 0.05). In contrast, the addition of the two negative control proteins did not significantly decrease the number of adherent treponemes. These results demonstrate that Tp0155 and Tp0483 can directly compete with the binding of T. pallidum to fibronectin.
Attachment of mammalian cells to Tp0155 and Tp0483. Adhesion assays were performed to investigate the ability of Tp0155 and Tp0483 to mediate attachment of mammalian cells. Cell lines were obtained from the American Type Culture Collection (Manassas, Va.) and included the colon carcinoma cell line SW480, which produces fibronectin, and the pituitary cell line AtT20, which does not synthesize fibronectin or express fibronectin-binding receptors. Assays were performed as previously described (38) . Non-tissue culturetreated ELISA plates (Fisher Scientific, Pittsburgh, Pa.) were coated for 24 h at 4°C with 100 l of either of the recombinant T. pallidum proteins Tp0155 and Tp0483 or the negative control protein bovine serum albumin at a concentration of 20 g/ml in PBS. Wells coated with Tp0155 and Tp0483 demonstrated a fourfold-higher level of attachment of SW480 than AtT20 cells (data not shown). These results are consistent with the capacity of Tp0155 and Tp0483 to attach to fibronectin. Summary. This study extends previous investigations on the specific interaction of T. pallidum with fibronectin (1, 4, 15, 16,  21, 33, 34, 45-47) . Adherence assays identified the T. pallidum open reading frames Tp0155 and Tp0483 as encoding proteins that bind fibronectin. The predicted sizes of Tp0155 (35.8 kDa) and Tp0483 (40 kDa) are similar to the sizes estimated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis for the previously identified T. pallidum fibronectinbinding proteins P3 (32 kDa) and P2 (37 kDa) (46) . The binding of fibronectin to Tp0155 and Tp0483 is characteristic of specific receptor-ligand interactions, in that each molecule bound increasing fibronectin concentrations in a dose-dependent manner. Recombinant Tp0155 and Tp0483 inhibited attachment of T. pallidum to fibronectin, and the two proteins mediated attachment of the fibronectin-producing SW480 cell line. These results identify Tp0155 and Tp0483 as T. pallidum fibronectin-binding proteins.
As discussed in this report, Tp0155 preferentially bound the matrix form of fibronectin, whereas Tp0483 bound both the soluble and matrix forms of fibronectin. The two forms of fibronectin exist in different conformational states, with cryptic epitopes becoming exposed during fibronectin matrix assembly (44, 51) . Similar differential fibronectin binding abilities have been observed in group B streptococci (43) , Streptococcus sanguis (25) , Yersinia sp. (40) , and human immunodeficiency virus (44) , which bind preferentially to the matrix form of fibronectin, and Streptococcus pyogenes (30) and Staphylococcus aureus (24) , which bind to both soluble and matrix forms. The differential fibronectin binding capabilities of Tp0155 and Tp0483 would each result in T. pallidum attachment to cells and tissues. Tp0155 could mediate attachment of T. pallidum through direct binding of matrix-associated fibronectin. Further, Tp0483 could mediate both direct binding to cells via matrixassociated fibronectin, as well as indirect binding via soluble fibronectin serving as a bridging molecule between the T. pallidum Tp0483 receptor and cells. Such an attachment mechanism has been observed with other bacterial pathogens, including S. aureus (17, 32, 42) , S. pyogenes (6, 29, 31) , and Mycobacterium leprae (39) . These alternative mechanisms for promoting attachment of T. pallidum to fibronectin may allow the pathogen to colonize different niches in the host.
The presence of multiple fibronectin-binding proteins within one organism has been observed for other pathogenic bacteria, including Mycobacterium, Streptococcus, and Staphylococcus spp. (22) . We now show that T. pallidum similarly expresses multiple fibronectin-binding adhesins. In addition, T. pallidum also possesses a laminin-binding adhesin (5) . The exact contribution of each of these adhesins, as well as other currently unidentified T. pallidum adhesins, to the infection process remains to be determined. However, it is likely that the role in treponemal pathogenesis played by an individual adhesin is particularly suited to the stage of infection and/or tissue niche, with appropriate redundancy existing between these adhesins to ensure successful establishment of infection. Additional characterization of these treponemal fibronectin-binding adhesins, as well as other T. pallidum molecules that interact with host components, will further our understanding of the pathogenesis of T. pallidum.
We are grateful to Lynn Barrett for assistance with recombinant expression, Julie Yabu and Melissa Steadele for their assistance with the cell adhesion assays, and Barbara Molini and Sheila Lukehart for their gift of T. pallidum.
This work was supported by Public Health Service grant AI-51334 from the National Institutes of Health, faculty awards from the University of Washington (Royalty Research Fund and STD New Investigator Award, AI-31448), and the Canadian Institutes of Health Research.
